Pyridopyrazine derivatives and their use

US8912189B2 · kind B2 · utility

Assignee

• Aeterna Zentaris, Inc. · DE

Inventors

• Matthias Gerlach · Wächtersbach, DE
• Irene Seipelt · Offenbach, DE
• Lars Blumenstein · Frankfurt am Main, DE
• Gilbert Mueller · Frankfurt am Main, DE
• Eckhard Guenther · Maintal, DE
• Tilmann Schuster · Großostheim, DE
• Michael Teifel · Weiterstadt, DE

Key dates

• Filing date: Apr 4, 2012
• Grant date: Dec 16, 2014
• Expiry date: Jun 21, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides new pyridopyrazine compounds of Formula (I) which are suitable for the treatment or prevention of physiological and/or pathophysiological states mediated and/or modulated by signal transduction pathways and/or enzymes in mammals and in particular in humans.